ARTICLE | Company News
Altimmune, U.S. Department of Health and Human Services infectious news
August 8, 2016 7:00 AM UTC
HHS’s Biomedical Advanced Research and Development Authority (BARDA) awarded Altimmune a five-year contract worth up to $120.2 million to develop its anthrax vaccine candidate NasoShield. Altimmune ...